Hyperglycemia and Loss of Redox Homeostasis in COVID-19 Patients

• Published in: Cells (Basel, Switzerland) Vol. 11; no. 6; p. 932
• Main Authors: Soto, María Elena, Guarner-Lans, Verónica, Díaz-Díaz, Eulises, Manzano-Pech, Linaloe, Palacios-Chavarría, Adrían, Valdez-Vázquez, Rafael Ricardo, Aisa-Álvarez, Alfredo, Saucedo-Orozco, Huitzilihuitl, Pérez-Torres, Israel
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 09-03-2022; MDPI
• Subjects: Antibodies; Antioxidants; Antioxidants - metabolism; Chronic obstructive pulmonary disease; Consent; Coronaviruses; COVID-19; E coli; Edema; Glucose; Glucose metabolism; Glutathione; Glutathione - metabolism; Homeostasis; homeostasis redox; Humans; Hydrogen sulfide; Hyperglycemia; Hyperglycemia - complications; Hyperinsulinemia; Hypertension; Immune system; Infections; Insulin; Insulin - metabolism; Insulin Resistance; Isoprostanes; Laboratories; Lipid peroxidation; Metabolic syndrome; Metabolism; Nitrites; Nitrogen dioxide; Nitrotyrosine; Oxidation-Reduction; Oxidative Stress; Patients; Phlebotomy; Plasma; Pneumonia; Population studies; Proteins; SARS-CoV-2; Selenium; Sepsis; Severe acute respiratory syndrome coronavirus 2; Spectrophotometry; Sulfhydryl Compounds; Thiols; Tumor necrosis factor-TNF; Viral infections; Vitamin D; Vitamins; United States > US; homeostasis redox; hyperglycemia; SARS-CoV-2; selenium; H2S; nitrotyrosine; thiols; lipid peroxidation
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells11060932

The infection with SARS-CoV-2 impairs the glucose−insulin axis and this contributes to oxidative (OS) and nitrosative (NSS) stress. Here, we evaluated changes in glucose metabolism that could promote the loss of redox homeostasis in COVID-19 patients. This was comparative cohort and analytical study that compared COVID-19 patients and healthy subjects. The study population consisted of 61 COVID-19 patients with and without comorbidities and 25 healthy subjects (HS). In all subjects the plasma glucose, insulin, 8-isoprostane, Vitamin D, H2S and 3-nitrotyrosine were determined by ELISA. The nitrites (NO2−), lipid-peroxidation (LPO), total-antioxidant-capacity (TAC), thiols, glutathione (GSH) and selenium (Se) were determined by spectrophotometry. The glucose, insulin and HOMA-IR (p < 0.001), 8-isoprostanes, 3-nitrotyrosine (p < 0.001) and LPO were increased (p = 0.02) while Vitamin D (p = 0.01), H2S, thiols, TAC, GSH and Se (p < 0.001) decreased in COVID-19 patients in comparison to HS. The SARS-CoV-2 infection resulted in alterations in the glucose−insulin axis that led to hyperglycemia, hyperinsulinemia and IR in patients with and without comorbidities. These alterations increase OS and NSS reflected in increases or decreases in some oxidative markers in plasma with major impact or fatal consequences in patients that course with metabolic syndrome. Moreover, subjects without comorbidities could have long-term alterations in the redox homeostasis after infection.